Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deletion of 13q14.3 and a candidate gene
KCNRG
(potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in
multiple myeloma
(MM).
KCNRG
protein may interfere with the normal assembly of the K+ channel proteins causing the suppression of Kv currents. We aimed to examine possible role of
KCNRG
haploinsufficiency in chronic lymphocytic leukemia (CLL) and MM cells. We performed detailed genomic analysis of the
KCNRG
locus; studied effects of the stable overexpression of
KCNRG
isoforms in RPMI-8226, HL-60, and LnCaP cells; and evaluated relative expression of its transcripts in various human lymphomas. Three MM cell lines and 35 CLL PBL samples were screened for
KCNRG
mutations.
KCNRG
exerts growth suppressive and pro-apoptotic effects in HL-60, LnCaP, and RPMI-8226 cells. Direct sequencing of
KCNRG
exons revealed point mutation delT in RPMI-8226 cell line. Levels of major isoform of
KCNRG
mRNA are lower in DLBL lymphomas compared to normal PBL samples, while levels of its minor mRNA are decreased across the broad range of the lymphoma types. The haploinsufficiency of
KCNRG
might be relevant to the progression of CLL and MM at least in a subset of patients.
...
PMID:Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region. 2023